Viridian Therapeutics Inc (NASDAQ:VRDN)
| 12.39 BATS BZX Real-Time Price As of 2:10pm ET |  +0.49 / +4.12%Today’s Change | 9.47 Today|||52-Week Range 22.00 | -37.33% Year-to-Date |
Latest VRDN News | Press Releases
No recent news for Viridian Therapeutics Inc.
Today’s Trading
| Previous close | 11.90 |
| Today’s open | 11.79 |
| Day’s range | 11.64 - 12.39 |
| Volume | 2,925 |
| Average volume (3 months) | 146,977 |
| Market cap | $379.2M |
Data as of 2:10pm ET, 05/27/2022
Growth & Valuation
| Earnings growth (last year) | +78.59% |
| Earnings growth (this year) | +44.11% |
| Earnings growth (next 5 years) | +7.59% |
| Revenue growth (last year) | +182.19% |
| P/E ratio | NM |
| Price/Sales | 79.53 |
| Price/Book | 6.03 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ABUSArbutus Biopharma Co... | +0.19 | +8.26% |
| --China Health Group I... | +0.02 | +6.67% |
| ESPREsperion Therapeutic... | +0.29 | +5.26% |
| ---- |
Data as of 2:15pm ET, 05/27/2022
Financials
| Next reporting date | August 10, 2022 |
| EPS forecast (this quarter) | -$0.88 |
| Annual revenue (last year) | $3.0M |
| Annual profit (last year) | -$79.4M |
| Net profit margin | -2,680.16% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Waltham, Massachusetts |
Forecasts
